Knight Therapeutics Inc. announced the resignation of Hillel Rosen and the appointment Ed Schutter to Knight's Board of Directors. Ed Schutter is President and CEO of Arbor Pharmaceuticals, LLC. Prior to Arbor, Ed served as President of Sciele Pharmaceuticals.